2017
DOI: 10.1101/104547
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Auditory prediction errors as individual biomarkers of schizophrenia

Abstract: Schizophrenia is a complex psychiatric disorder, typically diagnosed through symptomatic evidence collected through patient interview. We aim to develop an objective biologically-based computational tool which aids diagnosis and relies on accessible imaging technologies such as electroencephalography (EEG). To achieve this, we used machine learning techniques and a combination of paradigms designed to elicit prediction errors or Mismatch Negativity (MMN) responses. MMN, an EEG component elicited by unpredictab… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
16
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(16 citation statements)
references
References 38 publications
0
16
0
Order By: Relevance
“…In clinical practice, the potential biomarker may be referred by physicians when they gave advices to voluntary high-altitude immigrants. In parallel, it also helps to understand the pathophysiological processes associated with these neurobehavioral alterations and provide biologicallyrelevant targets that can guide high-altitude impairment prevention and novel treatment development (4,5).…”
mentioning
confidence: 99%
“…In clinical practice, the potential biomarker may be referred by physicians when they gave advices to voluntary high-altitude immigrants. In parallel, it also helps to understand the pathophysiological processes associated with these neurobehavioral alterations and provide biologicallyrelevant targets that can guide high-altitude impairment prevention and novel treatment development (4,5).…”
mentioning
confidence: 99%
“…One important branch of neuroimaging is the search for a biomarker in neurological, neuropsychiatric and neurodevelopmental disorders (including dyslexia). For instance, promising strides here have been made using various neuroimaging techniques in Alzheimer's disease (MRI [10], fMRI [11], PET [12] and MEG [13]), schizophrenia (PET [14], EEG [15] and MEG [16]), attention deficit hyperactivity disorder (ADHD) (MEG and structural MRI [17], DKI [18], MRI and MFC [19]) and dyslexia (MEG and structural MRI [17], structural MRI [20], ERPs [21,22], MEG [23] and fMRI [24]). It should be noted that some of the above cited papers explicitly claim the search for neuroimaging biomarkers, while others do not, but the results reported can be considered as potential candidates for neuroimaging biomarkers.…”
Section: A Brief Summary Of Neuroimaging Methods and Neuroimaging Resmentioning
confidence: 99%
“…There are pilot studies indicating it may be able to predict and be an objective indicator of people who would benefit from psychosocial interventions [9][10][11]. Being able to have more precise information on who would respond to interventions, especially psychosocial interventions that require a weekly commitment over months, would benefit participants and not expose people to the potentially demoralising effect of attending a therapy that they were not able to benefit from [12].…”
Section: Background and Rationalementioning
confidence: 99%
“…To classify the compensation and adaptation therapy responders and non-responders, class labels will be assigned to each participant. In PRoNTo, we will apply the support vector machine (SVM) and Gaussian process algorithms [24], which has shown to be effective in classifying schizophrenia patients using neuroimaging features [12]. The SVM training phase involves assigning weights to features and finding the hyperplane that maximises the margin between the groups of participants; the sign of the total feature weights multiplied by the test sample will determine the classification of participants.…”
Section: Study Periodmentioning
confidence: 99%